Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Herait, Patrice"'
Autor:
Coudé MM; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Laboratory of Hematology, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris and University Paris VII), Paris, France., Braun T; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Hematology Department, Hôpital Avicenne (Assistance Publique - Hôpitaux de Paris and University Paris XIII), Bobigny, France., Berrou J; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France., Dupont M; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France., Bertrand S; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France., Masse A; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France., Raffoux E; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Leukemia Unit, Hematology Department, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris and University Paris VII), Paris, France., Itzykson R; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Leukemia Unit, Hematology Department, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris and University Paris VII), Paris, France., Delord M; Bioinformatics, Institut Universitaire d'Hématologie, University Paris VII, Paris, France., Riveiro ME; Oncology Therapeutic Development, Clichy, France., Herait P; Oncoethix, Lausanne, Switzerland., Baruchel A; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Department of Pediatric Hemato-Immunology, Hôpital Robert Debré (Assistance Publique - Hôpitaux de Paris and University Paris VII), Paris, France., Dombret H; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Leukemia Unit, Hematology Department, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris and University Paris VII), Paris, France., Gardin C; Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France.; Hematology Department, Hôpital Avicenne (Assistance Publique - Hôpitaux de Paris and University Paris XIII), Bobigny, France.
Publikováno v:
Oncotarget [Oncotarget] 2015 Jul 10; Vol. 6 (19), pp. 17698-712.
Autor:
Boi M; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Gaudio E; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Bonetti P; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Kwee I; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland. Dalle Molle Institute for Artificial Intelligence (IDSIA), Manno, Switzerland. Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Bernasconi E; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Tarantelli C; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Rinaldi A; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Testoni M; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Cascione L; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland. IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Ponzoni M; Unit of Lymphoid Malignancies, Department of Onco-Haematology, San Raffaele Scientific Institute, Milan, Italy., Mensah AA; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland., Stathis A; IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Stussi G; IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Riveiro ME; OTD Oncology Therapeutic Development, Clichy, France., Herait P; Oncoethix, Lausanne, Switzerland., Inghirami G; Department of Pathology and Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Turin, Italy. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York. Department of Pathology and NYU Cancer Center, New York University School of Medicine, New York, New York., Cvitkovic E; OTD Oncology Therapeutic Development, Clichy, France. Oncoethix, Lausanne, Switzerland., Zucca E; IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Bertoni F; Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland. IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. frbertoni@mac.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Apr 01; Vol. 21 (7), pp. 1628-38. Date of Electronic Publication: 2015 Jan 26.
Autor:
Odore, Elodie, Lokiec, François, Cvitkovic, Esteban, Bekradda, Mohamed, Herait, Patrice, Bourdel, Fabrice, Kahatt, Carmen, Raffoux, Emmanuel, Stathis, Anastasios, Thieblemont, Catherine, Quesnel, Bruno, Cunningham, David, Riveiro, Maria, Rezaï, Keyvan, Lokiec, François, Riveiro, Maria E, Rezaï, Keyvan
Publikováno v:
Clinical Pharmacokinetics; Mar2016, Vol. 55 Issue 3, p397-405, 9p
Autor:
Emanuele Zucca, Maurilio Ponzoni, Georg Stussi, Andrea Rinaldi, Eugenio Gaudio, Maria E. Riveiro, Ivo Kwee, Afua Adjeiwaa Mensah, Giorgio Inghirami, Luciano Cascione, Paola Bonetti, Monica Testoni, Esteban Cvitkovic, Patrice Herait, Francesco Bertoni, Chiara Tarantelli, Elena Bernasconi, Michela Boi, Anastasios Stathis
Purpose: In cancer cells, the epigenome is often deregulated, and inhibition of the bromodomain and extra-terminal (BET) family of bromodomain-containing proteins is a novel epigenetic therapeutic approach. Preliminary results of an ongoing phase I t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284aeef37ffe983ed839d6362729793b